To determine whether temporal changes in scintigraphic and bone radiographic findings have prognostic significance in patients with skeletal metastases from breast cancer.
Clinical information and films were retrospecitvely reviewed in 101 randomly selected patients with skeletal metastases. Images from sequential bone scans and bone radiographs were correlated with survival after detection of the metastases.
Time to detection of skeletal metastases and the length of time for which patients were classified as radiologically stable after development of skeletal metastases correlated with survival (r=0.843; r=0.821, respectively). Failure to develop a radiographically and scintigraphically stable pattern after treatment was associated with significantly decreased survival compared with the rest of the patients (mean survival 2.1±1.3 years vs 4.3±2.3 years; p<0.001). Scintigraphic regression of metastases was associated with significant survival benefit and longer stabilization of disease compared to all other patterns (mean survival 5.0±2.7 years for regressive disease vs 3.7±1.9 years for stable disease and 2.2±1.3 years for progressive disease; p<0.001).
Sequential scintigraphic and radiographic imaging is useful in breast cancer patients not only for detection of metastases and monitoring of treatment effect, but also because these studies provide valuable prognostic information.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Tomin R, Donegan WL. Screening for recurrent breast cancer — its effectiveness ad prognostic value. J Clin Oncol 1987; 5: 62–67.
Stierer M, Rosen HR. Influence of early diagnosis on prognosis of recurrent breast cancer. Cancer 1989; 64: 1128–1131.
Zwaveling A, Albers GHR, Felthuis W, Hermans J. An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 1987; 34: 194–197.
Hortobagyi GN. Bone metastases in breast cancer patients. Semin Oncol 1991; 18 [Suppl 5]: 11–15.
Hayes DF, Kaplan WD. Evaluation of patients following primary therapy. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. Philadelphia: Lippincott, 1991: 505–525.
Coleman RE, Mashiter G, Whitaker KB, Moss DW, Rubens RD, Fogelman I. Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 1988; 29: 1354–1359.
Plotkin D, Lechner JJ, Jung WE, Rosen PJ. Tamoxifen flare in advanced breast cancer. JAMA 1978; 240: 2644–2646.
Janicek MJ, Hayes FD, Kaplan WD. Healing flare in skeletal metastases from breast cancer. Radiology 1994; 192: 201–204.
Zar JH. Biostatistical analysis, 2nd edn. Englewood Cliffs, NJ: Prentice-Hall, 1984: 185–205.
Blomqvist CB, Elomaa I, Virkkunen P, Porkka L, Karonen SL, Risteli L, Risteli J. The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism. Cancer 1987; 60: 2907–2912.
Bitran JD, Bekerman C, Desser R. The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer. Cancer 1980; 45: 1562–1568.
Libshitz HI, Hortobagyi GN. Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 1981; 7: 159–165.
Citrin DL, Hougen C, Zweibel W, Schlise S, Pruitt B, Ershler W, Davis TE, Harberg J, Cohen AI. The use of serial bone scans in assessing response of bone. Cancer 1981; 47: 680–685.
Kagan AR, Steckel RJ, Bassett W, Gold RH. Radiologic contributions to cancer management. Bone metastases. Am J Roentgenol 1986; 147: 305–312.
Legault-Poisson S, Jolivet J, Poisson R, Beretta-Piccoli M, Band PR. Tamoxifen-induced tumor stimulation and withdrawal response. Cancer Treat Rep 1979; 63: 1839–1841.
Rossleigh MA, Lovegrove FTA, Reynolds PM, Byrne MJ, Whitney BP. The assessment of response to therapy of bone metastases in breast cancer. Aust N Z J Med 1984; 14: 19–22.
McNeil BJ. Value of bone scanning in neoplastic disease. Semin Nucl Med 1984; 14: 277–286.
Glynne-Jones R, Young T, Ahmed A, Ell PJ, Berry RJ. How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol (R Coll Radiol) 1991; 3: 65–72.
Bedwinek JM, Lee J, Fineberg B, Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 1981; 47: 2232–2235.
Bedwinek JM, Munro D, Fineberg B. Local-regional treatment of patients with simultaneous local-regional recurrence and distant metastases following mastectomy. Am J Clin Oncol 1983; 6: 295–300.
Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL. The results of radiation therapy for isolated local regional recurrence. Int J Radiat Oncol Biol Phys 1991; 21: 299–310.
About this article
Cite this article
Janicek, M.J., Shaffer, K. Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: value of sequential imaging in predicting outcome. Skeletal Radiol. 24, 597–600 (1995). https://doi.org/10.1007/BF00204859
- Breast cancer
- Skeletal metastases
- Bone scintigraphy